Skip to main content

White Coat Hypertension: Definition, Terminology and Prevalence

  • Chapter
  • First Online:
Book cover White Coat Hypertension

Abstract

The medical visit, or more in general the situation of being in a clinical environment, often leads the patient to experience an alerting reaction and a transient increase in blood pressure (BP) levels [1–3], known as the “white coat effect” [4]. This represents a major problem associated with BP measurement in clinical practice, as it prevents BP measures obtained in the clinic from accurately reflecting the “true” subject’s blood pressure values. Although the first description of this phenomenon was performed by the end of the nineteenth century [5], it was thanks to the observations made by studies implementing sophisticated systems for continuous BP monitoring in ambulatory conditions that the nature and mechanisms responsible for the pressor response to the medical visit could be better understood [1, 3]. These pioneering studies not only provided direct and precise quantitative assessment of the BP rise associated with the doctor’s visit but also indicated that it is the alerting reaction and not the cuff inflation at the moment of BP measurement that causes this pressor response [1, 6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, Gregorini L, Zanchetti A (1983) Effects of blood-pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet 2(8352):695–698

    Article  PubMed  CAS  Google Scholar 

  2. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A (1983) Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 53(1):96–104

    Article  PubMed  CAS  Google Scholar 

  3. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A (1987) Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 9(2):209–215

    Article  PubMed  CAS  Google Scholar 

  4. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH (1988) How common is white coat hypertension? JAMA 259(2):225–228

    Article  PubMed  CAS  Google Scholar 

  5. Riva Rocci S (1897) The technique of sphygmomanometry. Gazz Med Torino 10:981–1017

    Google Scholar 

  6. Parati G, Pomidossi G, Casadei R, Mancia G (1985) Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. Hypertension 7(4):597–601

    Article  PubMed  CAS  Google Scholar 

  7. Little P, Barnett J, Barnsley L, Marjoram J, Fitzgerald-Barron A, Mant D (2002) Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ 325(7358):254

    Article  PubMed  PubMed Central  Google Scholar 

  8. Julius S, Mejia A, Jones K, Krause L, Schork N, van de Ven C, Johnson E, Petrin J, Sekkarie MA, Kjeldsen SE et al (1990) “White coat” versus “sustained” borderline hypertension in Tecumseh, Michigan. Hypertension 16(6):617–623

    Article  PubMed  CAS  Google Scholar 

  9. O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E et al (2013) European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31(9):1731–1768

    PubMed  Google Scholar 

  10. Parati G, Ulian L, Santucciu C, Omboni S, Mancia G (1998) Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 31(5):1185–1189

    Article  PubMed  CAS  Google Scholar 

  11. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G (1989) Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 13(6 Pt 1):647–655

    Article  PubMed  CAS  Google Scholar 

  12. Lantelme P, Milon H, Vernet M, Gayet C (2000) Difference between office and ambulatory blood pressure or real white coat effect: does it matter in terms of prognosis? J Hypertens 18(4):383–389

    Article  PubMed  CAS  Google Scholar 

  13. Palatini P, Palomba D, Bertolo O, Minghetti R, Longo D, Sarlo M, Pessina AC (2003) The white-coat effect is unrelated to the difference between clinic and daytime blood pressure and is associated with greater reactivity to public speaking. J Hypertens 21(3):545–553

    Article  PubMed  CAS  Google Scholar 

  14. Parati G, Omboni S, Mancia G (1996) Difference between office and ambulatory blood pressure and response to antihypertensive treatment. J Hypertens 14(6):791–797

    Article  PubMed  CAS  Google Scholar 

  15. Leary AC, Donnan PT, MacDonald TM, Murphy MB (2002) The white-coat effect is associated with increased blood pressure reactivity to physical activity. Blood Press Monit 7(4):209–213

    Article  PubMed  Google Scholar 

  16. Siegel WC, Blumenthal JA, Divine GW (1990) Physiological, psychological, and behavioral factors and white coat hypertension. Hypertension 16(2):140–146

    Article  PubMed  CAS  Google Scholar 

  17. Shimada K, Ogura H, Kawamoto A, Matsubayashi K, Ishida H, Ozawa T (1990) Noninvasive ambulatory blood pressure monitoring during clinic visit in elderly hypertensive patients. Clin Exp Hypertens A Theory Pract 12(2):151–170

    Article  CAS  Google Scholar 

  18. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A (1995) Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 13(12 Pt 1):1377–1390

    PubMed  CAS  Google Scholar 

  19. Mancia G, Omboni S, Parati G, Ravogli A, Sega R, Ulian L (1994) Ambulatory blood pressure monitoring in the diagnosis of hypertension and evaluation of antihypertensive drug efficacy. Blood Press Suppl 2:20–22

    PubMed  CAS  Google Scholar 

  20. Thijs L, Amery A, Clement D, Cox J, de Cort P, Fagard R, Fowler G, Guo C, Mancia G, Marin R et al (1992) Ambulatory blood pressure monitoring in elderly patients with isolated systolic hypertension. J Hypertens 10(7):693–699

    Article  PubMed  CAS  Google Scholar 

  21. Owens P, Atkins N, O’Brien E (1999) Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 34(2):267–272

    Article  PubMed  CAS  Google Scholar 

  22. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R, Sacchi N, Porcellati C (1995) White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens 8(8):790–798

    Article  PubMed  CAS  Google Scholar 

  23. Hoegholm A, Kristensen KS, Madsen NH, Svendsen TL (1992) White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients. Am J Hypertens 5(2):64–70

    PubMed  CAS  Google Scholar 

  24. Myers MG, Valdivieso M, Kiss A (2009) Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens 27(2):280–286

    Article  PubMed  CAS  Google Scholar 

  25. 1999 World Health Organization-International Society of hypertension guidelines for the management of hypertension. Guidelines subcommittee (1999). J Hypertens 17(2):151–183

    Google Scholar 

  26. Hypertension control. Report of a WHO Expert Committee (1996). World Health Organ Tech Rep Ser 862:1–83

    Google Scholar 

  27. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281–1357

    Article  PubMed  CAS  Google Scholar 

  28. Pickering T (1996) Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens 9(1):1–11

    Article  PubMed  CAS  Google Scholar 

  29. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M (2007) Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring. Int J Cardiol 117(3):355–359

    Article  PubMed  Google Scholar 

  30. Spence JD, Bass M, Robinson HC, Cheung H, Melendez LJ, Arnold JM, Manuck SB (1991) Prospective study of ambulatory monitoring and echocardiography in borderline hypertension. Clin Invest Med 14(3):241–250

    PubMed  CAS  Google Scholar 

  31. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ (2005) Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45(1):142–161

    Article  PubMed  CAS  Google Scholar 

  32. Dolan E, Stanton A, Atkins N, Den Hond E, Thijs L, McCormack P, Staessen J, O’Brien E (2004) Determinants of white-coat hypertension. Blood Press Monit 9(6):307–309

    Article  PubMed  CAS  Google Scholar 

  33. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C (1992) Variability between current definitions of ‘normal’ ambulatory blood pressure. Implications in the assessment of white coat hypertension. Hypertension 20(4):555–562

    Article  PubMed  CAS  Google Scholar 

  34. Staessen JA, Bieniaszewski L, O’Brien ET, Imai Y, Fagard R (1996) An epidemiological approach to ambulatory blood pressure monitoring: the Belgian population study. Blood Press Monit 1(1):13–26

    PubMed  Google Scholar 

  35. Imai Y, Nagai K, Sakuma M, Sakuma H, Nakatsuka H, Satoh H, Minami N, Munakata M, Hashimoto J, Yamagishi T et al (1993) Ambulatory blood pressure of adults in Ohasama, Japan. Hypertension 22(6):900–912

    Article  PubMed  CAS  Google Scholar 

  36. Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Van Hoof R, Amery AK (1991) Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol 67(8):723–727

    Article  PubMed  CAS  Google Scholar 

  37. Fagard RH, Cornelissen VA (2007) Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 25(11):2193–2198

    Article  PubMed  CAS  Google Scholar 

  38. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R (2006) Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47(5):846–853

    Article  PubMed  CAS  Google Scholar 

  39. Verdecchia P, Palatini P, Schillaci G, Mormino P, Porcellati C, Pessina AC (2001) Independent predictors of isolated clinic (‘white-coat’) hypertension. J Hypertens 19(6):1015–1020

    Article  PubMed  CAS  Google Scholar 

  40. Sega R, Cesana G, Milesi C, Grassi G, Zanchetti A, Mancia G (1997) Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. Hypertension 30(1 Pt 1):1–6

    Article  PubMed  CAS  Google Scholar 

  41. Martinez MA, Garcia-Puig J, Martin JC, Guallar-Castillon P, Aguirre de Carcer A, Torre A, Armada E, Nevado A, Madero RS (1999) Frequency and determinants of white coat hypertension in mild to moderate hypertension: a primary care-based study. Monitorizacion Ambulatoria de la Presion Arterial (MAPA)-area 5 working group. Am J Hypertens 12(3):251–259

    Article  PubMed  CAS  Google Scholar 

  42. Hoegholm A, Kristensen KS, Bang LE, Nielsen JW (1998) White coat hypertension and target organ involvement: the impact of different cut-off levels on albuminuria and left ventricular mass and geometry. J Hum Hypertens 12(7):433–439

    Article  PubMed  CAS  Google Scholar 

  43. Staessen JA, O’Brien ET, Amery AK, Atkins N, Baumgart P, De Cort P, Degaute JP, Dolenc P, De Gaudemaris R, Enstrom I et al (1994) Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens Suppl Off J Int Soc Hypertens 12(7):S1–S12

    CAS  Google Scholar 

  44. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, Black HR, Hamilton BP, Holland J, Nwachuku C et al (2002) Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 4(6):393–404

    Article  Google Scholar 

  45. Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290(2):199–206

    Article  PubMed  Google Scholar 

  46. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Oliveras A, Ruilope LM (2011) Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57(5):898–902

    Article  PubMed  Google Scholar 

  47. Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 57(6):1076–1080

    Article  PubMed  CAS  Google Scholar 

  48. Ahmed MI, Calhoun DA (2011) Resistant hypertension: bad and getting worse. Hypertension 57(6):1045–1046

    Article  PubMed  CAS  Google Scholar 

  49. Elliott WJ (2011) High prevalence of white-coat hypertension in Spanish resistant hypertensive patients. Hypertension 57(5):889–890

    Article  PubMed  CAS  Google Scholar 

  50. de la Sierra A, Banegas JR, Oliveras A, Gorostidi M, Segura J, de la Cruz JJ, Armario P, Ruilope LM (2012) Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens 30(6):1211–1216

    Article  PubMed  Google Scholar 

  51. Oikawa T, Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H, Komai R, Murai K, Hashimoto J, Totsune K et al (2006) Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens 24(9):1737–1743

    Article  PubMed  CAS  Google Scholar 

  52. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T et al (2008) European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on home blood pressure monitoring. J Hypertens 26(8):1505–1526

    Article  PubMed  CAS  Google Scholar 

  53. Parati G, Bilo G, Mancia G (2003) White coat effect and white coat hypertension: what do they mean? Cardiovasc Rev Rep 24:477–484

    Google Scholar 

  54. Mancia G, Zanchetti A (1986) Handbook of Hypertension. Vol. 7. Elsevier B.V., pp. 125–152

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gianfranco Parati MD, FESC .

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Parati, G., Ochoa, J.E., Lombardi, C., Bilo, G. (2015). White Coat Hypertension: Definition, Terminology and Prevalence. In: White Coat Hypertension. Springer, Cham. https://doi.org/10.1007/978-3-319-07410-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-07410-8_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-07409-2

  • Online ISBN: 978-3-319-07410-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics